T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at Diagnosis
Florus C. de Jong(Erasmus MC Cancer Institute), Tahlita C.M. Zuiverloon(Erasmus MC), Ellen C. Zwarthoff(Erasmus MC), Jolien T. M. Mensink(Erasmus MC Cancer Institute), Robert F. Hoedemaeker(PathoFinder (Netherlands)), Joep J. de Jong(Erasmus MC Cancer Institute), Deric K. E. van der Schoot(Amphia Ziekenhuis), Vebjørn Kvikstad(Stavanger University Hospital), Joost L. Boormans(Erasmus MC), Egbert R. Boevé(Hôpitaux Universitaires Henri-Mondor)
Cited by 27
Related Papers
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
|Nature Communications|2021|381